A Systematic Review of Anxiety and Depressive Symptoms Among Women Experiencing Vasomotor Symptoms Across Reproductive Stages in the US
Open Access
- 1 February 2025
- journal article
- review article
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 537-552
Abstract
Purpose: Vasomotor symptoms (VMS) due to menopause affect up to 80% of women and are associated with fatigue, depressive symptoms, and anxiety although the exact nature of these associations is not fully understood. This systematic review aimed to examine the existing evidence on the relationship between VMS, fatigue, depressive symptoms, and anxiety among women in any stage of reproductive aging in the United States. Methods: A comprehensive search of MEDLINE and Embase databases was performed to identify observational studies (2010– 2022) that reported on the target population. Exposure of interest was VMS; data related to the outcomes of interest (measures of fatigue, depressive symptoms, and/or anxiety) were extracted and analyzed descriptively. Results: Twenty-six studies met the inclusion criteria, with 19 reporting on depressive symptom outcomes, 16 on anxiety outcomes, and none on fatigue. The mean age of women with VMS ranged from 41.3 to 62.0 years; 34.8% to 91.1% of women were premenopausal or in the late stage of reproductive aging, 0.6% to 61% were perimenopausal or in menopause transition, and 0% to 49% were postmenopausal. The most frequent comorbidities were hypertension and diabetes. Baseline depressive symptom rates ranged from 1.4% to 58%, with higher rates and more severe symptoms among women with more frequent and severe VMS. Anxiety rates at baseline ranged from 2.2% to 52%, with higher rates reported among women with frequent VMS. Anxiety levels varied, with the highest levels observed among women with sleep disturbances and severe hot flashes. In regression model analyses, VMS were associated with increased risk, duration, frequency, and severity of both depressive symptoms and anxiety. Conclusion: VMS are strongly and consistently associated with depressive symptoms and anxiety, negatively affecting a woman’s health beyond physical discomfort. There is a need to reduce this burden and improve quality of life for women with VMS.Keywords
This publication has 46 references indexed in Scilit:
- Relationships between Menopausal and Mood Symptoms and EEG Sleep Measures in a Multi-ethnic Sample of Middle-Aged Women: The SWAN Sleep StudySLEEP, 2011
- Duration of Menopausal Hot Flushes and Associated Risk FactorsObstetrics & Gynecology, 2011
- A comparative study of menopausal hot flashes and their psychosocial correlates in Taiwan and the United StatesMaturitas, 2010
- History of hot flashes and aortic calcification among postmenopausal womenMenopause, 2010
- Lifetime History of Major Depression Predicts the Development of the Metabolic Syndrome in Middle-Aged WomenPsychosomatic Medicine, 2009
- Menopausal Complaints Are Associated With Cardiovascular Risk FactorsHypertension, 2008
- Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatmentAmerican Journal of Obstetrics and Gynecology, 2007
- Risk for New Onset of Depression During the Menopausal TransitionArchives of General Psychiatry, 2006
- The Relationship of Longitudinal Change in Reproductive Hormones and Vasomotor Symptoms during the Menopausal TransitionThe Journal of Clinical Endocrinology & Metabolism, 2005
- Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive reviewHealth and Quality of Life Outcomes, 2005